A new study provides more evidence that sildenafil (Viagra) which is used to treat erectile dysfunction (ED) may help protect against Alzheimer’s disease (AD). The large […]

Three times as many patients treated with intravenous (IV) tenecteplase (TNK) administered up to 24 hours after symptom onset achieve major reperfusion without symptomatic intracranial hemorrhage […]

A wise medical precept is attributed to Theodore Woodward, MD (1914-2005): “When you hear hoofbeats, think of horses, not zebras.” Primary care pediatricians, however, often find […]

Disappointing phase 3 trial results of a drug approved for the treatment of amyotrophic lateral sclerosis (ALS) may prompt the manufacturer to voluntarily pull it from […]

The US Food and Drug Administration (FDA) has put off a decision expected this month on whether to approve donanemab for Alzheimer’s disease (AD).  Instead, the […]

In the phase 3b ELEVATE trial, preventive treatment with atogepant (Qulipta) significantly reduced monthly migraine days compared to placebo in adults with episodic migraine in whom […]

Black people, men, older adults, and those living in rural communities are less likely to receive thrombolytic therapy after ischemic stroke, early research shows. “The findings […]

WEST PALM BEACH, Fla. — Patient-reported outcomes (PROs) define the issues that matter to the patient, but their potential in multiple sclerosis (MS) is likely to […]

WEST PALM BEACH, FLORIDA — When evaluated at 3 or 12 months, serum neurofilament light chain (sNfL) levels were predictive of new or enlarging T2 lesions […]